Compare CHDN & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHDN | GRFS |
|---|---|---|
| Founded | 1928 | 1940 |
| Country | United States | Spain |
| Employees | N/A | 25247 |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.4B |
| IPO Year | 1995 | N/A |
| Metric | CHDN | GRFS |
|---|---|---|
| Price | $85.30 | $7.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 2 |
| Target Price | ★ $138.44 | $10.15 |
| AVG Volume (30 Days) | ★ 922.9K | 589.6K |
| Earning Date | 04-22-2026 | 07-28-2022 |
| Dividend Yield | 0.43% | ★ 1.80% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.49 | N/A |
| Revenue | ★ $1,809,800,000.00 | N/A |
| Revenue This Year | $5.75 | $4.49 |
| Revenue Next Year | $3.52 | $6.42 |
| P/E Ratio | ★ $15.58 | $18.67 |
| Revenue Growth | ★ 13.31 | N/A |
| 52 Week Low | $81.66 | $7.39 |
| 52 Week High | $118.46 | $11.14 |
| Indicator | CHDN | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 38.30 | 48.45 |
| Support Level | $83.19 | $7.87 |
| Resistance Level | $88.33 | $9.78 |
| Average True Range (ATR) | 2.51 | 0.21 |
| MACD | -0.61 | 0.02 |
| Stochastic Oscillator | 15.21 | 50.26 |
Churchill Downs Inc is a gaming entertainment, online wagering, and racing company. It operates through three business segments: Live and Historical Racing, Wagering Services, and Gaming. The Live and Historical Racing segment includes live and historical pari-mutuel racing. The Wagering Services segment includes the revenue and expenses from pari-mutuel wagers through TwinSpires, companies retail and online sports betting business and Gaming segment includes revenue and expenses for the casino properties and associated racetracks that support the casino license. The Gaming segment generates revenue and expenses from slot machines, video lottery terminals, video poker, HRMs, ancillary food and beverage services, hotel services, commission on pari-mutuel wagering, and racing events.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.